IBDEI2HT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39806,1,3,0)
 ;;=3^Family Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,39806,1,4,0)
 ;;=4^Z80.43
 ;;^UTILITY(U,$J,358.3,39806,2)
 ;;=^5063350
 ;;^UTILITY(U,$J,358.3,39807,0)
 ;;=Z80.6^^152^2001^25
 ;;^UTILITY(U,$J,358.3,39807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39807,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,39807,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,39807,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,39808,0)
 ;;=Z80.8^^152^2001^30
 ;;^UTILITY(U,$J,358.3,39808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39808,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,39808,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,39808,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,39809,0)
 ;;=Z81.8^^152^2001^35
 ;;^UTILITY(U,$J,358.3,39809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39809,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,39809,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,39809,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,39810,0)
 ;;=Z82.3^^152^2001^42
 ;;^UTILITY(U,$J,358.3,39810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39810,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,39810,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,39810,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,39811,0)
 ;;=Z82.49^^152^2001^24
 ;;^UTILITY(U,$J,358.3,39811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39811,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,39811,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,39811,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,39812,0)
 ;;=Z82.5^^152^2001^14
 ;;^UTILITY(U,$J,358.3,39812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39812,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,39812,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,39812,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,39813,0)
 ;;=Z82.61^^152^2001^13
 ;;^UTILITY(U,$J,358.3,39813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39813,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,39813,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,39813,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,39814,0)
 ;;=Z82.69^^152^2001^37
 ;;^UTILITY(U,$J,358.3,39814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39814,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,39814,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,39814,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,39815,0)
 ;;=Z83.3^^152^2001^20
 ;;^UTILITY(U,$J,358.3,39815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39815,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,39815,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,39815,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,39816,0)
 ;;=Z83.2^^152^2001^16
 ;;^UTILITY(U,$J,358.3,39816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39816,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,39816,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,39816,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,39817,0)
 ;;=Z82.71^^152^2001^40
 ;;^UTILITY(U,$J,358.3,39817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39817,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,39817,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,39817,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,39818,0)
 ;;=Z82.1^^152^2001^15
 ;;^UTILITY(U,$J,358.3,39818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39818,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
